Improving the methodology of clinical studies and regulatory practices in rare cancers
Task Force 1 seeks to overcome methodological studies and regulatory practices challenges in rare cancers.
RCE Goals & Task Forces
Throughout RCE’s history, the partnership has encouraged a collaborative relationship amongst stakeholder organisations that work together to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions and exchange best practice. Rare Cancers Europe is structured in the form of four task forces, each focusing on one of RCE’s four overarching goals.
More about these task forces
Improving the organisation of healthcare in rare cancers
Task Force 2 seeks to overcome organisational challenges of healthcare in rare cancers
Improving access to rare cancer treatments and standard of care
Task Force 3 seeks to improve access to rare cancers treatments and standard of care
Improving the education of healthcare professional and information on rare cancers
Task Force 4 seeks to promote educational efforts of healthcare professional and information on rare cancers